Safety Study to Evaluate Daptomycin in Non-infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis (MK-3009-021)

Summary

This study is to examine the safety of daptomycin in patients with End Stage Renal Disease.

Timeline

Start

2007-08-12

Primary completion

2008-05-12

Completion

2008-05-12

Publications

• Benziger DP, Pertel PE, Donovan J, Yankelev S, Schwab RJ, Swan SK, Cannon C. Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Clin Nephrol. 2011 Jan;75(1):63-9.

Drugs

Indications